The stel­lar an­ti­body shop at Re­gen­eron wins a ‘break­through’ tag for its next big PhI­II drug

Re­gen­eron $REGN has one of the best track records in the busi­ness when it comes to build­ing amaz­ing­ly ef­fec­tive an­ti­bod­ies. It did it with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.